GERN today
$1.02+$0.05 (+4.70%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourBullish
1 hourSymmetric Triangle
15 minSymmetric Triangle
5 minSymmetric Triangle
Daily trend turns up above $1.19
Key levels
Resistance$1.19
Resistance$1.08
Support$1.00
Support$0.84
Latest news & SEC filings
NewsGeron Corporation will share RYTELO findings at ASH 2026
EarningsGeron Posts Q3 2026 Financials
EarningsGeron Discusses Third-Quarter 2026 Results on Conference Call
All GERN news →About Geron
Geron is a drugmaker that develops and sells treatments for cancers of the blood. Its lead medicine, RYTELO (imetelstat), works by blocking the telomerase enzyme and is cleared for use in adults who have lower-risk myelodysplastic syndromes and need red blood cell infusions. The company also studies imetelstat in myelofibrosis and other myeloid cancers. It markets mainly to physicians and patients in the United States and is working to reach patients in Europe.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
GERON CORP (GERN)
What Is the Price Target for GERN?
SEPT Low Target
$2.50
SEPT Mid Target
$3.75
SEPT High Target
$5.00
Analyst Consensus
$3.75
Is GERN a Buy or Sell Right Now?
Thesis
- •Revenue growing -60.2% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for GERN.
Start Free Trial →Is GERN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$215.66
2
Moat Score
NONE
1/9
Piotroski Score
-3.0
Altman Z-Score
What Is Smart Money Doing with GERN?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Spiegel Robert J. | director | Buy | 6,351 | $8K | Sep 30, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →GERN Growth Story
Revenue YoY
-60.2%
3yr Revenue CAGR
N/A%
EPS Growth YoY
51.85%
FCF Growth YoY
N/A%
Revenue Trend
DECLINING
Dark Pool Trades for GERN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for GERN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:25:45 | $1.02 | 4,909 | $$5K | BUY |
| 21:01:19 | $1.02 | 2,607 | $$3K | MIDPOINT |
| 21:01:09 | $1.02 | 3,518 | $$4K | SELL |
| 21:00:19 | $1.02 | 1,709 | $$2K | MIDPOINT |
| 21:00:01 | $1.02 | 69,523 | $$71K | BUY |
5 dark pool trades shown · $$84K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for GERN
PREVIEWSEPT Investing provides real-time options flow tracking for GERN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $1.5 | Mar 19 | 128 | $$10 | 1 | SWEEP |
| CALL | $1.5 | Mar 19 | 128 | $$100 | 10 | SWEEP |
| CALL | $1.5 | Jan 15 | 65 | $$500 | 100 | BLOCK |
| CALL | $1 | Nov 20 | 9 | $$750 | 150 | BLOCK |
| CALL | $1.5 | Nov 20 | 9 | $$10 | 2 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for GERON CORP (GERN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (5 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →GERN — frequently asked questions
What is GERN stock price today?
GERON CORP (GERN) is at $1.02, up 4.70% (+$0.05) at the Nov 11, 2026 close.
Why is GERN stock moving today?
Latest GERN news — Nov 4, 2026: Geron Corporation will share RYTELO findings at ASH 2026 · Nov 4, 2026: Geron Posts Q3 2026 Financials
What is the GERN price target?
The average analyst price target for GERN is $3.75, ranging from $3 to $5, based on 2 analysts. Latest: Wedbush maintains on Oct 29, 2026.
What do analysts rate GERN?
Analyst ratings for GERN: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did GERN beat earnings?
GERN last reported on Aug 6, 2026: EPS -$0.02 vs -$0.01 expected — a miss of 124.7%.
Does GERN pay a dividend?
GERN does not currently pay a dividend.
What are GERN support and resistance levels?
Support: $1.00, $0.84, $0.75. Resistance: $1.08, $1.19, $1.28.
What are insiders doing with GERN?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on GERN?
Nov 4, 2026: Geron Corporation will share RYTELO findings at ASH 2026 · Nov 4, 2026: Geron Posts Q3 2026 Financials · Nov 4, 2026: Geron Discusses Third-Quarter 2026 Results on Conference Call